18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors.

Alexia RivasJulie DelyonAntoine MartineauEstelle BlancClara AllayousLaetitia Da MedaPascal MerletCéleste LebbéBarouyr BaroudjianLaetitia Vercellino

Published in: Cancers (2022)

The evaluation of response to immunotherapy using metabolic imaging with PERCIST5 and imPERCIST5 was significantly associated with OS in patients with advanced or metastatic melanoma.

Keyphrases

pet ct
positron emission tomography
pet imaging
high resolution
computed tomography
mass spectrometry
photodynamic therapy